AGP Executive Report
Last update: 2 hours agoSwatch vs. “drop culture” chaos: Swatch says it’s “chilling” after Royal Pop queues turned into brawls and police pepper-spraying in multiple cities, with the Swiss watchmaker closing and then reopening some stores as it tried to restore order. Biotech deal with Swiss reach: SERB Pharmaceuticals will buy Idefirix® (imlifidase) rights from Hansa Biopharma for €115m, covering the EU plus Switzerland and MENA—aimed at highly sensitised kidney-transplant patients. Infrastructure in focus: STRABAG (with ZÜBLIN) has won major work on Germany’s Pfaffensteig Tunnel, a key link to cut Stuttgart–Swiss border journey times. Finance & regulation: Revolut launches its first physical crypto card (Dogecoin-themed LED) in the UK and EEA—explicitly excluding Switzerland—while FERMA publishes sustainability-linked insurance principles to standardise credible claims. Tech from EPFL: EPFL researchers report a new robot-learning approach that lets different robot designs pick up the same human-demonstrated skills without custom code.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.